company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 12:08:13+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2795000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 12:08:13+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2795000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 12:08:13+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2795000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 12:08:13+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5959000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 12:08:13+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11778000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 12:08:13+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17737000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 12:08:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14942000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 12:08:13+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,88000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 12:08:13+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,26000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 12:08:13+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-62000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 12:08:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15004000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 12:08:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15004000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 12:08:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15004000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 12:08:13+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-15004000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 12:08:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44069000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 12:08:13+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.34
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 12:08:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44069000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 12:08:13+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.34
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 12:08:13+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44100000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 12:08:13+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.34
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 11:56:59+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,51961000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 11:56:59+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,51961000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 11:56:59+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,51961000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 11:56:59+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7325000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 11:56:59+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12488000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 11:56:59+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19813000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 11:56:59+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,32148000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 11:56:59+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,74000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 11:56:59+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,46000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 11:56:59+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-28000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 11:56:59+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,32120000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 11:56:59+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,32120000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 11:56:59+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,32120000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 11:56:59+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,32120000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 11:56:59+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44719000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 11:56:59+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.72
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 11:56:59+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,46032000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 11:56:59+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.7
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 11:56:59+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44600000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 11:56:59+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.72
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 09:54:19+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,78172000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 09:54:19+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,78172000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 09:54:19+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,78172000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 09:54:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8310000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 09:54:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12943000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 09:54:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21253000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 09:54:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,56919000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 09:54:19+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,41000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 09:54:19+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,128000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 09:54:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,87000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 09:54:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,57006000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 09:54:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,57006000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 09:54:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,57006000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 09:54:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,57006000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 09:54:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,49532000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 09:54:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.15
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 09:54:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,50334000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 09:54:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.13
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 09:54:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,49600000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 09:54:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.15
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 09:08:19+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,87496000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 09:08:19+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,87496000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 09:08:19+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,87496000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 09:08:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9205000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 09:08:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14168000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 09:08:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23373000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 09:08:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,64123000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 09:08:19+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,34000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 09:08:19+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,176000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 09:08:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,142000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 09:08:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,64265000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 09:08:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,64265000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 09:08:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,64265000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 09:08:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,64265000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 09:08:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,49708000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 09:08:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.29
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 09:08:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,51001000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 09:08:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.26
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 09:08:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,49800000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 09:08:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.29
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 12:46:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,87945000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 12:46:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,87945000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 12:46:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,87945000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 12:46:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11480000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 12:46:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16307000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 12:46:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,27787000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 12:46:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,60158000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 12:46:30+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,14000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 12:46:30+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,194000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 12:46:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,180000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 12:46:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,60338000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 12:46:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,60338000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 12:46:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,60338000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 12:46:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,60338000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 12:46:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,50034000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 12:46:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.21
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 12:46:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,51048000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 12:46:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.18
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 12:46:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,49900000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 12:46:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.21
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,29455000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,29455000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,29455000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9715000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21239000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,30954000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1499000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,248000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,246000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1253000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1253000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1253000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1253000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,49852000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.03
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,50823000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.02
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,49800000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.03
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 12:01:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,24228000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 12:01:44+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,24228000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 12:01:44+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,24228000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 12:01:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10955000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 12:01:44+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18562000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 12:01:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,29517000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 12:01:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5289000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 12:01:44+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,307000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 12:01:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,307000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 12:01:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4982000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 12:01:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4982000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 12:01:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4982000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 12:01:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4982000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 12:01:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,49800000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 12:01:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.1
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 12:01:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,49800000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 12:01:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.1
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 12:01:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,50240000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 12:01:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.1
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 12:45:35+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,21863000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 12:45:35+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,21863000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 12:45:35+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,21863000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 12:45:35+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12353000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 12:45:35+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,20011000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 12:45:35+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,32364000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 12:45:35+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10501000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 12:45:35+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,335000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 12:45:35+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,335000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 12:45:35+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10166000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 12:45:35+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10166000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 12:45:35+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10166000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 12:45:35+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10166000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 12:45:35+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,50800000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 12:45:35+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.2
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 12:45:35+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,50800000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 12:45:35+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.2
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 12:45:35+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,50354000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 12:45:35+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.2
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 15:05:18+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5102000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 15:05:18+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5102000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 15:05:18+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5102000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 15:05:18+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10999000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 15:05:18+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,20233000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 15:05:18+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,31232000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 15:05:18+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-26130000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 15:05:18+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,308000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 15:05:18+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,308000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 15:05:18+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-25822000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 15:05:18+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-25822000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 15:05:18+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-25822000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 15:05:18+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-25822000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 15:05:18+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,50600000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 15:05:18+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.51
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 15:05:18+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,50600000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 15:05:18+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.51
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 15:05:18+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,50500000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 15:05:18+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.51
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12728000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12728000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12728000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9375000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21539000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,30914000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-18186000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,288000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,220000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,508000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17678000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17678000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17678000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-17678000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,50600000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.35
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,50600000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.35
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,50411000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.35
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 08:17:02+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7603000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 08:17:02+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7603000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 08:17:02+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7603000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 08:17:02+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9716000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 08:17:02+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,22332000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 08:17:02+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,32048000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 08:17:02+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-24445000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 08:17:02+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,269000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 08:17:02+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,60000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 08:17:02+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,329000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 08:17:02+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-24116000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 08:17:02+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24116000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 08:17:02+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24116000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 08:17:02+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-24116000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 08:17:02+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,50200000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 08:17:02+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.48
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 08:17:02+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,50200000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 08:17:02+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.48
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 08:17:02+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,50635000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 08:17:02+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.48
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 13:06:01+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4361000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 13:06:01+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4361000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 13:06:01+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4361000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 13:06:01+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11516000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 13:06:01+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21994000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 13:06:01+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,33510000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 13:06:01+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-29149000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 13:06:01+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,243000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 13:06:01+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,58000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 13:06:01+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,301000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 13:06:01+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-28848000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 13:06:01+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-28848000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 13:06:01+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-28848000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 13:06:01+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-28848000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 13:06:01+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,50600000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 13:06:01+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.57
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 13:06:01+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,50600000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 13:06:01+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.57
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 13:06:01+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,50746000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 13:06:01+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.57
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:32:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10751000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:32:31+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10751000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:32:31+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10751000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:32:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8977000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:32:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,27435000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:32:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,36412000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:32:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-25661000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:32:31+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,224000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:32:31+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,55000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:32:31+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,279000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:32:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-25382000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:32:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-25382000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:32:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-25382000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:32:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-25382000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:32:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,50800000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:32:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.5
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:32:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,50800000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:32:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.5
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:32:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,51055000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:32:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.5
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12750000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12750000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12750000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10848000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,32238000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,43086000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-30336000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,214000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,60000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,274000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-30062000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30062000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30062000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-30062000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,50900000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.58
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,50900000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.58
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,50907000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.58
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 08:49:56+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10785000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 08:49:56+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10785000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 08:49:56+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10785000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 08:49:56+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11717000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 08:49:56+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,26692000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 08:49:56+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,38409000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 08:49:56+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-27624000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 08:49:56+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,200000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 08:49:56+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,62000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 08:49:56+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,262000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 08:49:56+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-27362000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 08:49:56+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27362000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 08:49:56+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27362000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 08:49:56+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-27362000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 08:49:56+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,51600000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 08:49:56+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.53
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 08:49:56+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,51600000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 08:49:56+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.53
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 08:49:56+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,51356000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 08:49:56+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.53
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 15:30:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10950000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 15:30:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10950000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 15:30:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10950000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 15:30:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11219000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 15:30:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,26089000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 15:30:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,37308000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 15:30:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-26358000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 15:30:12+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,140000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 15:30:12+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,62000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 15:30:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,202000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 15:30:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-26156000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 15:30:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-26156000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 15:30:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-26156000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 15:30:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-26156000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 15:30:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,51300000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 15:30:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.51
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 15:30:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,51300000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 15:30:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.51
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 15:30:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,51466000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 15:30:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.51
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 11:43:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9336000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 11:43:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9336000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 11:43:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9336000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 11:43:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11103000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 11:43:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,27508000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 11:43:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,38611000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 11:43:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-29275000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 11:43:26+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,112000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 11:43:26+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,62000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 11:43:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,174000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 11:43:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-29101000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 11:43:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-29101000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 11:43:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-29101000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 11:43:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-29101000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 11:43:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,52000000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 11:43:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.56
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 11:43:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,52000000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 11:43:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.56
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 11:43:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,51545000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 11:43:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.56
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,21179000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,21179000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,21179000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11125000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,26193000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,37318000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-16139000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,96000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,62000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,158000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15981000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15981000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15981000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-15981000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,51600000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.31
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,51600000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.31
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,51664000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.31
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:16:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8562000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:16:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8562000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:16:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8562000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:16:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7890000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:16:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,22749000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:16:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,30639000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:16:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-22077000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:16:54+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,112000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:16:54+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,88000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:16:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,200000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:16:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-21877000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:16:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21877000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:16:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21877000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:16:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-21877000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:16:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,54700000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:16:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.4
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:16:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,54700000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:16:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.4
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:16:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,54492000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:16:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.4
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:10:38+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,44900000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:10:38+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,44900000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:10:38+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,44900000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:10:38+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,13329000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:10:38+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,33983000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:10:38+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,47312000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:10:38+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2412000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:10:38+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,122000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:10:38+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,68000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:10:38+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,190000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:10:38+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2222000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:10:38+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2222000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:10:38+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2222000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:10:38+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2222000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:10:38+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,55600000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:10:38+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.04
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:10:38+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,55600000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:10:38+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.04
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:10:38+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,61680000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:10:38+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.04
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 15:58:09+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,13795000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 15:58:09+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,13795000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 15:58:09+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13795000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 15:58:09+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12459000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 15:58:09+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,31733000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 15:58:09+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,44192000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 15:58:09+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-30397000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 15:58:09+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-30397000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 15:58:09+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,347000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 15:58:09+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30050000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 15:58:09+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30050000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 15:58:09+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-30050000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 15:58:09+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,68300000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 15:58:09+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.44
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 15:58:09+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,68300000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 15:58:09+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.44
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 15:58:09+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,68004000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 15:58:09+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.44
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,22393000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,22393000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,22393000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14373000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,37568000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,51941000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-29548000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,574000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,157000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,731000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-28817000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-347000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-29164000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-29164000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-29164000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,63100000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.44
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,63100000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.44
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,63130000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.44
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:46:48+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,19850000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:46:48+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,19850000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:46:48+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,19850000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:46:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,15647000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:46:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,28757000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:46:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,44404000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:46:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-24554000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:46:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-24554000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:46:48+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,542000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:46:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24012000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:46:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24012000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:46:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-24012000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:46:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,68600000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:46:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.35
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:46:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,68600000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:46:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.35
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:46:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,68285000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:46:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.35
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:03:06+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,26430000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:03:06+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,26430000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:03:06+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,26430000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:03:06+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14896000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:03:06+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,33173000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:03:06+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,48069000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:03:06+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-21639000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:03:06+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,653000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:03:06+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,653000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:03:06+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-20986000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:03:06+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20986000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:03:06+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20986000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:03:06+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-20986000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:03:06+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,67700000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:03:06+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.31
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:03:06+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,67700000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:03:06+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.31
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:03:06+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,68532000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:03:06+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.31
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 09:17:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,29144000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 09:17:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,29144000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 09:17:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,29144000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 09:17:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,15758000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 09:17:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,31568000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 09:17:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,47326000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 09:17:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-18182000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 09:17:21+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,638000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 09:17:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,638000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 09:17:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17544000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 09:17:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17544000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 09:17:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17544000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 09:17:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-17544000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 09:17:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,67500000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 09:17:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.26
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 09:17:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,67500000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 09:17:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.26
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 09:17:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,68799000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 09:17:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.26
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,34195000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,34195000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,34195000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,18165000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,26382000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,44547000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10352000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2226000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,50207000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,52433000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,42081000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-542000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,41539000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,41539000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,41539000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,67800000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.61
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,67800000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.61
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,68656000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.61
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,26614000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,26614000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,26614000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,23105000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,36101000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,59206000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-32592000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:27+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,833000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,833000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-31759000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-31759000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-31759000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-31759000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,69000000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.46
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,69000000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.46
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,69711000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.46
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 07:52:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,23570000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 07:52:47+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,23570000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 07:52:47+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,23570000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 07:52:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,22572000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 07:52:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,39063000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 07:52:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,61635000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 07:52:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-38065000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 07:52:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-38065000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 07:52:47+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1157000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 07:52:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-36908000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 07:52:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-36908000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 07:52:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-36908000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 07:52:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73800000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 07:52:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.5
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 07:52:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,73800000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 07:52:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.5
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 07:52:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73379000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 07:52:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.5
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 17:09:00+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,24090000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 17:09:00+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,24090000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 17:09:00+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,24090000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 17:09:00+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,20703000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 17:09:00+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,37914000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 17:09:00+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 17:09:00+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,58617000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 17:09:00+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-34527000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 17:09:00+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1339000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 17:09:00+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1339000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 17:09:00+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-33188000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 17:09:00+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-33188000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 17:09:00+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-33188000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 17:09:00+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-33188000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 17:09:00+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,75400000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 17:09:00+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.44
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 17:09:00+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75400000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 17:09:00+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.44
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 17:09:00+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,74611000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 17:09:00+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.44
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,64608000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,64608000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,64608000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,15827000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,36148000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,51975000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,12633000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,4427000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2144000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2283000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,14916000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-1157000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,13759000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,13759000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,13759000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73400000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.2
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,73400000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.2
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73136000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.2
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 16:32:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4852000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 16:32:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4852000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 16:32:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4852000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 16:32:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,20612000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 16:32:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,33242000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 16:32:07+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 16:32:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,53854000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 16:32:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-49002000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 16:32:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1371000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 16:32:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1371000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 16:32:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-47631000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 16:32:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-47631000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 16:32:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-47631000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 16:32:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-47631000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 16:32:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,75600000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 16:32:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.63
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 16:32:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75600000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 16:32:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.63
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 16:32:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,75454000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 16:32:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.63
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 17:11:06+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,13031000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 17:11:06+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,13031000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 17:11:06+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13031000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 17:11:06+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,52531000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 17:11:06+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,31340000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 17:11:06+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 17:11:06+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,83871000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 17:11:06+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-70840000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 17:11:06+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,955000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 17:11:06+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,955000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 17:11:06+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-69885000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 17:11:06+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-69885000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 17:11:06+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-69885000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 17:11:06+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-69885000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 17:11:06+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,76800000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 17:11:06+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.91
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 17:11:06+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,76800000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 17:11:06+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.91
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 17:11:06+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,76543000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 17:11:06+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.91
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 17:19:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,14884000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 17:19:44+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,14884000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 17:19:44+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14884000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 17:19:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,20437000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 17:19:44+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,30727000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 17:19:44+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,15535000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 17:19:44+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 17:19:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,66699000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 17:19:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-51815000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 17:19:44+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1515000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 17:19:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1515000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 17:19:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-50300000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 17:19:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-50300000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 17:19:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-50300000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 17:19:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-50300000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 17:19:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,77400000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 17:19:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.65
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 17:19:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,77400000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 17:19:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.65
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 17:19:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,77229000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 17:19:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.65
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,42822000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,42822000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,42822000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,21525000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,28695000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,2272000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,52492000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9670000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,6194000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-4769000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1425000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8245000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8245000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8245000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8245000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,77900000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.07
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,77900000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.07
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,77845000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.07
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:33:32+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4113000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:33:32+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4113000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:33:32+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4113000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:33:32+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,24206000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:33:32+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,27972000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:33:32+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,26000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:33:32+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,52204000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:33:32+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-48091000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:33:32+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3248000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:33:32+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3248000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:33:32+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-44843000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:33:32+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-44843000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:33:32+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-44843000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:33:32+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-44843000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:33:32+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,97500000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:33:32+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.46
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:33:32+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,97500000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:33:32+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.46
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:33:32+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,98195000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:33:32+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.46
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:11:06+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5182000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:11:06+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5182000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:11:06+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5182000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:11:06+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,89545000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:11:06+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,32131000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:11:06+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,132000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:11:06+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,121808000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:11:06+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-116626000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:11:06+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2657000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:11:06+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2657000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:11:06+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-113969000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:11:06+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-113969000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:11:06+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-113969000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:11:06+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-113969000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:11:06+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,98200000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:11:06+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.16
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:11:06+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,98200000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:11:06+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.16
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:11:06+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,98595000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 17:11:06+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.16
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 17:19:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6391000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 17:19:44+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6391000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 17:19:44+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6391000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 17:19:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,20081000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 17:19:44+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,46105000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 17:19:44+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,19000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 17:19:44+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-13720000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 17:19:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,52485000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 17:19:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-46094000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 17:19:44+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1551000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 17:19:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1551000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 17:19:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-44543000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 17:19:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-44543000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 17:19:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-44543000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 17:19:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-44543000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 17:19:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,99000000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 17:19:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.45
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 17:19:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,99000000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 17:19:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.45
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 17:19:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,98709000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 17:19:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.45
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8182000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8182000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8182000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,57195000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,38334000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-67000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,95462000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-87280000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2018000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,9206000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-6608000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,580000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-86700000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-86700000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-86700000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-86700000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,99300000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.85
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,99300000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.85
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,99339000.0
Momenta Pharmaceuticals Inc,MNTA,,0001235010,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.85
